Issued Patents All Time
Showing 1–25 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11678658 | Devices, systems, and methods for modeling ocular translaminar pressure gradients | Tasneem Putliwala Sharma, Colleen McDowell, Husain Lohawala | 2023-06-20 |
| 10138483 | Transferrin/transferrin receptor-mediated siRNA delivery | Jon E. Chatterton | 2018-11-27 |
| 9752147 | RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions | Jon E. Chatterton, Martin B. Wax | 2017-09-05 |
| 9562230 | Transferrin/transferrin receptor-mediated siRNA delivery | Jon E. Chatterton | 2017-02-07 |
| 9550994 | RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma | Wan-Heng Wang, Loretta McNatt, Jon E. Chatterton | 2017-01-24 |
| 9476047 | RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions | Jon E. Chatterton, Martin B. Wax | 2016-10-25 |
| 9422556 | RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis | Jon E. Chatterton, David P. Bingaman, Martin B. Wax, Adrian M. Timmers | 2016-08-23 |
| 9173896 | RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions | Jon E. Chatterton, Martin B. Wax | 2015-11-03 |
| 9139834 | RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis | Jon E. Chatterton, David P. Bingaman, Martin B. Wax, Adrian M. Timmers | 2015-09-22 |
| 9114152 | Transferrin/transferrin receptor-mediated siRNA delivery | Jon E. Chatterton | 2015-08-25 |
| 9040494 | RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma | Wan-Heng Wang, Loretta McNatt, Jon E. Chatterton | 2015-05-26 |
| 8865670 | RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma | Jon E. Chatterton, David P. Bingaman, Martin B. Wax, Adrian M. Timmers | 2014-10-21 |
| 8754202 | RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis | Jon E. Chatterton, David P. Bingaman, Martin B. Wax, Adrian M. Timmers | 2014-06-17 |
| 8399653 | Transferrin/transferrin receptor-mediated siRNA delivery | Jon E. Chatterton | 2013-03-19 |
| 8389496 | Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma | Robert J. Wordinger | 2013-03-05 |
| 8173617 | RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma | Wan-Heng Wang, Loretta McNatt, Jon E. Chatterton | 2012-05-08 |
| 8168609 | RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders | Jon E. Chatterton | 2012-05-01 |
| 8063013 | Method of treating glaucoma comprising administering a composition comprising human BMP7 | Robert J. Wordinger | 2011-11-22 |
| 7973019 | Transferrin/transferrin receptor-mediated siRNA delivery | Jon E. Chatterton | 2011-07-05 |
| 7947660 | RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma | Wan-Heng Wang, Loretta McNatt, Jon E. Chatterton | 2011-05-24 |
| 7807363 | Superoxide dismutase-2 expression for glaucoma diagnosis | Wan-Heng Wang, Loretta McNatt, Peter G. Klimko | 2010-10-05 |
| 7807355 | Diagnostics and therapeutics for glaucoma | John Fingert, Loretta McNatt, Edwin M. Stone, Wan-Heng Wang | 2010-10-05 |
| 7744873 | Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin | Robert J. Wordinger | 2010-06-29 |
| 7662389 | Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents | Wan-Heng Wang, Loretta McNatt | 2010-02-16 |
| 7598288 | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma | Mark R. Hellberg, Iok-Hou Pang, Peggy Hellberg, Loretta McNatt, Wan-Heng Wang | 2009-10-06 |